Synonyms: Arcalyst® | IL-1 Trap | interleukin-1 Trap
rilonacept is an approved drug (FDA (2008), EMA (2009))
Compound class:
Peptide
Comment: Rilonacept is a fusion protein consisting of the binding domains of the IL-1 receptor (IL-1R) and the IL-1 receptor accessory protein (IL-1RAcP) linked to the Fc portion of human IgG1.
|
Classification | |
Compound class | Peptide |
Approved drug? | Yes (FDA (2008), EMA (2009)) |
International Nonproprietary Names | |
INN number | INN |
8750 | rilonacept |
Synonyms |
Arcalyst® | IL-1 Trap | interleukin-1 Trap |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 217 |
Other databases | |
CAS Registry No. | 501081-76-1 |
ChEMBL Ligand | CHEMBL1201830 |
DrugBank Ligand | DB06372 |
GtoPdb PubChem SID | 178103396 |
Search PubMed clinical trials | rilonacept |
Search PubMed titles | rilonacept |
Search PubMed titles/abstracts | rilonacept |
Wikipedia | Rilonacept |